Treatment of Langerhans cell histiocytosis: it is time to learn from the past: response to Minkov and Rodriguez-Galindo

Br J Haematol. 2015 Oct;171(1):150-1. doi: 10.1111/bjh.13371. Epub 2015 Mar 30.

Authors

Carl E Allen^{1

2}, Kenneth L McClain^{3

4}

Affiliations

¹ Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA. [email protected].
² Division of Pediatric Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA. [email protected].
³ Texas Children's Cancer Center, Baylor College of Medicine, Houston, TX, USA.
⁴ Division of Pediatric Hematology/Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA.

No abstract available

Keywords: Langerhans cell histiocytosis; cytarabine; prednisone; vinblastine.

Publication types

Letter
Comment

MeSH terms

Histiocytosis, Langerhans-Cell / drug therapy*
Humans

Grants and funding